Bioventus Vs. Perspective Therapeutics Industry Stock Comparison

Buy

97

BVS
Bioventus

Last Price:

6.37

Seasonality Move:

89.36%

Buy

52

CATX
Perspective Therapeutics

Last Price:

1.60

Seasonality Move:

2.9%

Buy

97

Bioventus (BVS) is a Buy

Is Bioventus a Buy, Sell or Hold?

The current Bioventus [BVS] share price is $6.38. The Score for BVS is 97, which is 94% above its historic median score of 50, and infers lower risk than normal.
BVS is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

Buy

52

Perspective Therapeutics (CATX) is a Buy

Is Perspective Therapeutics a Buy, Sell or Hold?

The current Perspective Therapeutics [CATX] share price is $1.60. The Score for CATX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
CATX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BVS Stock Price Chart

What is Bioventus's stock price today?

The Bioventus share price today is $6.38
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BVS is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

The Perspective Therapeutics share price today is $1.60
The current trend is moderately bearish and CATX is experiencing slight buying pressure.

BVS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.44	Buy
Relative Strength Index (14 RSI):	73.08	Buy
Chaikin Money Flow:	-226866	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(3.95 - 5.63)	Buy
Bollinger Bands (100):	(4.36 - 5.42)	Buy

CATX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.05	Buy
Relative Strength Index (14 RSI):	49.16	Sell
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.53 - 1.77)	Sell
Bollinger Bands (100):	(0.67 - 1.53)	Buy

BVS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	5.87	Buy
20-day SMA:	4.84	Buy
50-day SMA:	5	Buy
200-day SMA:	4.32	Buy
8-day EMA:	5.89	Buy
20-day EMA:	5.27	Buy
50-day EMA:	4.98	Buy
200-day EMA:	4.47	Buy

CATX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.69	Sell
20-day SMA:	1.69	Sell
50-day SMA:	1.47	Buy
200-day SMA:	0.71	Buy
8-day EMA:	1.66	Sell
20-day EMA:	1.65	Sell
50-day EMA:	1.46	Buy
200-day EMA:	0.91	Buy

Bioventus Earnings Growth & BVS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.11 per share, an increase this year of $0.58 per share, and an increase next year of $0.17 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bioventus Technical Analysis

	May 6	May 7	May 8	May 9	May 10	May 13	May 14	May 15	May 16	May 17
	May
	06	07	08	09	10	13	14	15	16	17
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

	May 6	May 7	May 8	May 9	May 10	May 13	May 14	May 15	May 16	May 17
	May
	06	07	08	09	10	13	14	15	16	17
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):